Best Buy Co., Inc.'s average stock price target has been raised by analysts from $71.61 to $72.22, with a potential upside of approximately 12% based on the recent closing price. The consensus rating for the stock remains "Hold" among 27 analysts, despite the increased price target. Investors can find more detailed price target data and analyst recommendations within the provided resources.

Intuitive Surgical (ISRG) has appointed Taylor Patton as its new Chief Commercial and Marketing Officer, effective July 1, 2026. Patton, currently global senior vice president of its endoluminal business, will succeed Henry Charlton, who will transition to senior vice president of global business operations. This change aims to support the company's continued global growth in minimally invasive care.

Activist investor Voss Capital is advocating for Sempra to spin off its Texas electricity unit, Oncor. This urging was communicated through a letter, as reported by Reuters. The news highlights an activist push for corporate restructuring within Sempra.

Microchip Technology (MCHP) has launched the dsPIC33CK Value Line digital signal controllers, targeting cost-sensitive real-time control applications. These new devices offer essential performance such as 100 MHz processing and high-resolution PWM, starting at $0.51 with consistent pricing regardless of order volume. They are designed to simplify system design and reduce costs in industrial, automotive, consumer, and medical applications.

Macy's Inc (M) shares rose 6.7% to $22.45, with a 95.7% increase over the past year. However, GuruFocus's GF Value indicates that the stock is significantly overvalued at 47.8% above its estimated fair value of $15.19. The company has a GF Score of 73/100, reflecting above-average quality, but insiders have sold $2.9 million worth of stock recently with no buying activity, raising concerns about its current valuation and growth prospects.

Microchip Technology Inc. has launched its dsPIC33CK Value Line family of Digital Signal Controllers (DSCs) designed for cost-sensitive real-time control applications. These DSCs offer deterministic processing, high-resolution PWM, and a 12-bit ADC, enabling applications like motor FOC and precision sensing without unnecessary features. The Value Line DSCs provide consistent pricing across all purchase volumes and boast automotive-grade reliability, simplifying design and production planning for various industries.

Dollar General shareholders are set to vote on a board-level human rights policy amidst pressure from institutional and faith-based investors. Concurrently, the company has announced a CEO succession plan targeting a leadership transition in 2027. These developments place Dollar General's governance, risk management, and operational continuity under increased scrutiny for investors, as the stock has shown mixed performance recently.

Chinese biopharmaceutical firm Innovent Biologics and U.S. pharma giant Pfizer have formed a global licensing and collaboration deal worth up to $10.5 billion to develop 12 early-stage cancer medicines. The agreement includes an upfront payment of $650 million to Innovent and up to $9.85 billion in potential milestone payments. The partnership encompasses a portfolio of antibody-drug conjugates and multi-specific antibodies, with varying development and commercialization rights across different programs and regions.

Arista Networks CFO Chantelle Yvette Breithaupt sold 2,448 shares of the company's common stock for $384,336 on May 26, 2026, pursuant to a pre-established trading plan. Following the sale, she directly owns 64,408 shares. Despite a strong 67% gain over the past year, InvestingPro analysis suggests the stock is currently overvalued, with a P/E ratio of 53.09.

Andreas Bechtolsheim, a 10% owner of Arista Networks (NYSE:ANET), sold approximately $34.5 million worth of common stock on May 26, 2026, through a Rule 10b5-1 trading plan. The sales involved 210,000 shares at prices ranging from $154.4979 to $160.0051 per share, held indirectly by a family trust. Despite a 67% return over the past year, InvestingPro analysis suggests the stock is currently overvalued, yet analysts like TD Cowen and Piper Sandler have recently raised their price targets for Arista Networks following strong Q1 2026 earnings.